Varicella-zoster virus immediate-early protein 62 blocks interferon regulatory factor 3 (IRF3) phosphorylation at key serine residues: a novel mechanism of IRF3 inhibition among herpesviruses.
J. Virol., Sep;84(18):9240-53 (2010)
Identification and functional characterization of the Varicella zoster virus ORF11 gene product.
Virology., Mar;412(1):156-66 (2011)
Mutagenesis of varicella-zoster virus glycoprotein I (gI) identifies a cysteine residue critical for gE/gI heterodimer formation, gI structure, and virulence in skin cells.
J. Virol., May;85(9):4095-110 (2011)
Varicella-zoster virus infection triggers formation of an interleukin-1Î² (IL-1Î²)-processing inflammasome complex.
J. Biol. Chem., May;286(20):17921-33 (2011)
Structure-function analysis of varicella-zoster virus glycoprotein H identifies domain-specific roles for fusion and skin tropism.
Proc. Natl. Acad. Sci. U.S.A., Nov;108(45):18412-7 (2011)
Signal transducer and activator of transcription 3 (STAT3) and survivin induction by varicella-zoster virus promote replication and skin pathogenesis.
Proc. Natl. Acad. Sci. U.S.A., Jan;109(2):600-5 (2012)
Varicella in the fetus and newborn.
Semin Fetal Neonatal Med., Aug;14(4):209-17 (2009)
The replication cycle of varicella-zoster virus: analysis of the kinetics of viral protein expression, genome synthesis, and virion assembly at the single-cell level.
J. Virol., Apr;83(8):3904-18 (2009)
Regulation of the ORF61 promoter and ORF61 functions in varicella-zoster virus replication and pathogenesis.
J. Virol., Aug;83(15):7560-72 (2009)
Mutagenesis of varicella-zoster virus glycoprotein B: putative fusion loop residues are essential for viral replication, and the furin cleavage motif contributes to pathogenesis in skin tissue in vivo.
J. Virol., Aug;83(15):7495-506 (2009)
Anti-glycoprotein H antibody impairs the pathogenicity of varicella-zoster virus in skin xenografts in the SCID mouse model.
J. Virol., Jan;84(1):141-52 (2010)
Functions of the unique N-terminal region of glycoprotein E in the pathogenesis of varicella-zoster virus infection.
Proc. Natl. Acad. Sci. U.S.A., Jan;107(1):282-7 (2010)
Age-related increase in the frequency of CD4(+) T cells that produce interferon-gamma in response to staphylococcal enterotoxin B during childhood.
J. Infect. Dis., Dec;200(12):1921-7 (2009)
Analysis of the functions of glycoproteins E and I and their promoters during VZV replication in vitro and in skin and T-cell xenografts in the SCID mouse model of VZV pathogenesis.
Curr. Top. Microbiol. Immunol., 342:129-46 (2010)
Immune responses to mumps vaccine in adults who were vaccinated in childhood.
J. Infect. Dis., Jun;197(12):1669-75 (2008)
Humoral and cellular immunity to varicella-zoster virus: an overview.
J. Infect. Dis., Mar;197 Suppl 2:S58-60 (2008)
Functions of Varicella-zoster virus ORF23 capsid protein in viral replication and the pathogenesis of skin infection.
J. Virol., Oct;82(20):10231-46 (2008)
Development of recombinant varicella-zoster viruses expressing luciferase fusion proteins for live in vivo imaging in human skin and dorsal root ganglia xenografts.
J. Virol. Methods., Dec;154(1-2):182-93 (2008)
Cellular and viral factors regulate the varicella-zoster virus gE promoter during viral replication.
J. Virol., Oct;81(19):10258-67 (2007)
Aberrant infection and persistence of varicella-zoster virus in human dorsal root ganglia in vivo in the absence of glycoprotein I.
Proc. Natl. Acad. Sci. U.S.A., Aug;104(35):14086-91 (2007)